Involvement of Helicaobacter pylori and hepatitis C virus in the crosstalk toward hepato-gastro carcinogenesis.
Involvement of Helicaobacter pylori and hepatitis C virus in the crosstalk toward hepato-gastro carcinogenesis.
批准号:
11470133
负责人:
SHIRAI Mutsunori
金额:
$2.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Th1 and Th2 cells play a central role in immunoregulation during infection. We show that H.pylori induces Th1 cytokine responses early (2wk) but predominantly Th2 responses later (6wk) in infection. The switch is principally mediated by urease-specific CD4^+T cells, and correlates with a loss of urease-specific high avidity JNK^+ Th1 and gain of low avidity JNK^- (possibly Th2) cells at the later stage of infection, concomitant with a 100-fold higher colonization level of H.pylori at 6 wk than at 2wk that might tolerize high avidity Th1 cells. Furthermore, differentiation of HIV gp160-specific CD4^+ Th and CD8^+ CTL into effector cells is impaired in 6-wk H.pylori-infected mice immunized with vaccinia expressing gp160, and serum IL-12 stimulated by vaccinia infection is barely detectable. Adoptive transfer of urease-specific Th2 cells to mice infected only with gp160-expressing vaccinia abrogates Th1 polarization of the gp120 response, downmodulates virus-specific CTL responses, and delays virus clearance. Therefore, the H.pylori urease-mediated immunoregulation in the switch from JNK^+ Th1 to JNK^-Th2 phenotype, and the preceding low IL-12 response are likely critical steps in the impairment of antiviral immunity. On the other hand, hepatitis C virus (HCV) is well known as a causative agent of hepatome. HCV core gene expression in the human host cells activated NFκB, a transcriptional upregulatory element for inflammatory cytokines and adhesins at 24hr post transfection, resulting in high production of COX-2 and prostaglandin E2 proteins. That suggest that HCV core expression causing inflammatory cytokines and adhesins in the host cells accerates hapato-gastro carcinogenesis.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shirai M., et al.: "Activation of Helicobacter pylori ureA promoter by a hybrid Escherichia coli-H. pylori rpoD gene in E.coli."Gene. 239. 351-359 (1999)
Shirai M. 等人:“大肠杆菌中混合型大肠杆菌-幽门螺杆菌 rpoD 基因激活幽门螺杆菌 ureA 启动子。”基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaki T., et al.: "Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma."Hepatology,. 29. 379-384 (1999)
Masaki T. 等人:“肝细胞癌中 C 末端 Src 激酶 (Csk) 活性降低。”Hepatology,。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akada JK, 他: "In vitro anti-Helicobacterpylori activities of new rifamycin derivative"Antimicrobial Agents Chemotherapy. 43. 1072-1076 (1999)
Akada JK 等人:“新型利福霉素衍生物的体外抗幽门螺杆菌活性”Antimicrobial Agents Chemotherapy 43. 1072-1076 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shirai M., et al.: "Accumulation of polyphosphale granules in Helicobacter pylori cells under anaerobic conditions."J.Med.Microbiol.. 49. 513-519 (2000)
Shirai M., et al.:“厌氧条件下幽门螺杆菌细胞中多磷颗粒的积累。”J.Med.Microbiol.. 49. 513-519 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shirai M., et al.: "Impaired development of HIV-1 gp160-specific CD8^+cytotoxic T cells by a delayed switch from Th1 to Th2 cytokine phenotype in mice with Helicobacter pylori infection."Eur.J.Immunol.. 31. 516-526 (2001)
Shirai M. 等人:“幽门螺杆菌感染小鼠中从 Th1 到 Th2 细胞因子表型的延迟转换导致 HIV-1 gp160 特异性 CD8+ 细胞毒性 T 细胞的发育受损。”Eur.J.Immunol.. 31。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
Search for a novel anti-pathogen defense system by studying host-pathogen interactions
-
批准号:15K09568
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2015
-
负责人:SHIRAI Mutsunori
-
依托单位:
Development of killer T cell vaccine against HCV env HVRI
-
批准号:08670347
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:SHIRAI Mutsunori
-
依托单位:
Peptide vaccine for killer T cell induction against hepatitis C virus
-
批准号:06670560
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1994
-
负责人:SHIRAI Mutsunori
-
依托单位:
海外基金